📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
7 articles
AVG GRADE
HIGH
score: 0.50
SENTIMENT
NEUTRAL
TOTAL VIEWS
19
INSM Stock Analysis & AI Grade: HIGH
7 articles analyzed · Sentiment: NEUTRAL · AI-powered equity research
RECENT COVERAGE · 8 ARTICLES
Morning Market Movers: CLRO, TDUP, SITM, INSM See Big Swings
Premarket trading activity in CLRO, TDUP, SITM, and INSM reflects typical morning price discovery mechanisms rather than fundamental...
Here’s Why Baron Health Care Fund Remains Bullish on Insmed (INSM)
Baron Capital's Health Care Fund posted Q2 2026 returns of 11.99%, marginally outperforming the Russell 3000 Health Care Index at...
Insmed Incorporated’s (INSM) Commercial Acceleration Overshadows Q1 Stumble
INSM is experiencing commercial acceleration momentum that is offsetting weaker Q1 operational results. This bifurcated performance...
Concerns Over the Pace of its Brinsupri’s Launch Hurt Insmed (INSM)
Insmed (INSM) faced downward pressure following concerns regarding the commercial launch pace of Brinsupri, a key pipeline asset. The...
Investors’ Concerns Hurt Insmed Incorporated (INSM) Despite Better-Than-Expected Results
Insmed Incorporated (INSM) delivered earnings results that exceeded consensus expectations in the second quarter, yet the stock faced...
GFL Environmental (GFL) Slid Following the Deal Reveal
GFL Environmental experienced downward pressure following announcement of a significant transaction, though the full details remain...
Insmed Incorporated (INSM) Discusses 12-Month Results From Ongoing TPIP Open-Label Extension Study in PAH Patients - Slideshow (NASDAQ:INSM) 2026-07-16
Insmed Incorporated (INSM) presented interim 12-month efficacy and safety data from its ongoing TPIP open-label extension study in...
Insmed Incorporated (INSM) Discusses 12-Month Results From Ongoing TPIP Open-Label Extension Study in PAH Patients Transcript
Insmed (INSM) released 12-month interim data from its TPIP open-label extension trial in pulmonary arterial hypertension (PAH) patients....
RELATED TICKERS
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice